|
?:authorAffiliation
|
-
[\'Department of Politics and International Relations, University of Oxford, Oxford, United Kingdom.\', \'Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA.\', \'Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, Massachusetts, USA.\', \'ASAPP, Inc, NY, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Independent Scholar, Worthing, United Kingdom.\', \'Independent Scholar, Oakland, California, USA.\', \'Health and Risk Communication Research Center, School of Public Health, University of Haifa, Haifa, Israel.\', \'Department of Population Health and Pathobiology, North Carolina State University, Raleigh, North Carolina, USA.\', \'Harvard Law School, Cambridge, Massachusetts, USA.\', \'Independent Scholar, Kelowna, British Columbia, Canada.\', \'Department of Physics, University of Oxford, Oxford, United Kingdom.\', \'Rethink Priorities, Redwood City, California, USA.\', \'Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.\', \'Waitlist Zero, Brooklyn, New York, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}